1. Van Nostrand D. New approaches in nuclear medicine for thyroid cancer. In: Wartofsky L, Van Nostrand D, editors. Thyroid cancer a comprehensive guide to clinical management. New York: Springer; 2006.
2. Millo C, Khorjekar G, Maass-Moreno R, Neumann R, Bluemke D. Comparison of PET images obtained with PET-CT vs PET-MR: a pilot study. J Nucl Med. 2012;53:551. abstract.
3. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F Fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49:68–78. 4.
4. Schneider MT, Garcia C, O’Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L. Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer. J Nucl Med (abstract) 2012;53(S):2067.
5. Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, Nicole A, Clarke PM, Franell K, McCready R, Smellie J, Frankly JA, John R, Nutting CM, Newbold K, Lemon C, Gerard G, Abdel-Hamid A, Hardman J, Macias E, Roques T, Whitaker S, Vijayn R, Alvarez P, Beare S, Forsyth S, Kadalayil L, Hackshaw A. Ablation with low-dose radioiodine and thyrotopin alfa in thyroid cancer. NEJM. 2012;366:1674–85.